DTIL
Price
$4.26
Change
+$0.13 (+3.15%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
45.79M
EDIT
Price
$2.56
Change
+$0.31 (+13.78%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
188.35M
28 days until earnings call
Interact to see
Advertisement

DTIL vs EDIT

Header iconDTIL vs EDIT Comparison
Open Charts DTIL vs EDITBanner chart's image
Precision BioSciences
Price$4.26
Change+$0.13 (+3.15%)
Volume$889
Capitalization45.79M
Editas Medicine
Price$2.56
Change+$0.31 (+13.78%)
Volume$180.26K
Capitalization188.35M
DTIL vs EDIT Comparison Chart in %
Loading...
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DTIL vs. EDIT commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a Hold and EDIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (DTIL: $4.13 vs. EDIT: $2.56)
Brand notoriety: DTIL and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 38% vs. EDIT: 419%
Market capitalization -- DTIL: $45.79M vs. EDIT: $188.35M
DTIL [@Biotechnology] is valued at $45.79M. EDIT’s [@Biotechnology] market capitalization is $188.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 2 bullish TA indicator(s).

  • DTIL’s TA Score: 5 bullish, 5 bearish.
  • EDIT’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, DTIL is a better buy in the short-term than EDIT.

Price Growth

DTIL (@Biotechnology) experienced а -9.63% price change this week, while EDIT (@Biotechnology) price change was +16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

DTIL is expected to report earnings on May 15, 2025.

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($188M) has a higher market cap than DTIL($45.8M). EDIT YTD gains are higher at: 101.181 vs. DTIL (8.399). DTIL has higher annual earnings (EBITDA): -16.57M vs. EDIT (-244.52M). EDIT has more cash in the bank: 221M vs. DTIL (77.2M). DTIL (29.7M) and EDIT (31.1M) have identical debt. DTIL has higher revenues than EDIT: DTIL (51.1M) vs EDIT (35.8M).
DTILEDITDTIL / EDIT
Capitalization45.8M188M24%
EBITDA-16.57M-244.52M7%
Gain YTD8.399101.1818%
P/E Ratio4.53N/A-
Revenue51.1M35.8M143%
Total Cash77.2M221M35%
Total Debt29.7M31.1M95%
FUNDAMENTALS RATINGS
DTIL vs EDIT: Fundamental Ratings
DTIL
EDIT
OUTLOOK RATING
1..100
5070
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DTIL's Valuation (30) in the Biotechnology industry is in the same range as EDIT (38). This means that DTIL’s stock grew similarly to EDIT’s over the last 12 months.

DTIL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as EDIT (100). This means that DTIL’s stock grew similarly to EDIT’s over the last 12 months.

DTIL's SMR Rating (97) in the Biotechnology industry is in the same range as EDIT (99). This means that DTIL’s stock grew similarly to EDIT’s over the last 12 months.

EDIT's Price Growth Rating (37) in the Biotechnology industry is in the same range as DTIL (64). This means that EDIT’s stock grew similarly to DTIL’s over the last 12 months.

EDIT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as DTIL (100). This means that EDIT’s stock grew similarly to DTIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILEDIT
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 27 days ago
78%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
DTIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS7.390.18
+2.50%
Aligos Therapeutics Inc
NWN40.600.88
+2.22%
Northwest Natural Holding Company
TE1.250.02
+1.63%
T1 Energy Inc.
ATXS5.430.07
+1.31%
Astria Therapeutics
CRM272.69N/A
N/A
Salesforce

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-1.67%
AXON - DTIL
46%
Loosely correlated
-6.35%
ORMP - DTIL
41%
Loosely correlated
-6.67%
ARRY - DTIL
39%
Loosely correlated
+12.54%
RENB - DTIL
36%
Loosely correlated
-5.85%
MURA - DTIL
33%
Loosely correlated
+1.21%
More